Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Cancer Meeting Summit 2025, France Women Oncology-2025, UK CANCER2025, Netherlands Breast Cancer Summit 2025, Italy Cancer Stem Cells 2025, Netherlands

Asia Pacific & Middle East

Canada

Blood Cancer 2022

About Conference

Cancer conferences is rejoiced to announce the commencement of “17th World Congress on Blood Cancer” during March 22-23, 2022 Osaka, Japan. The theme of the conference will be “Novel Research Techniques in Blood Cancer Treatment”.

Blood Cancer 2022 aims to bring together scientists, doctors, professors, lecturers in Oncology, researchers, students, training institutes, Laboratories, association and societies, and individuals have an interest in the field of Oncology & cancer.

Company organizes the conferences over 1600 Global Events inclusive of 1200+ Conferences, 600+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000+ scientific societies and publishes over 800 Open access Journals which contains over 50000 eminent personalities, reputed scientists as members of editorial board.

Why to Attend???

Blood Cancer 2022 Conference provides a global platform for exchanging ideas and makes us updated about the advancements and innovations in Oncology & cancer in a wide range. The conference regular sessions will be followed by the exhibition and sessions of Networking. Expecting leads and global business exposure from Directors, CEOs, and eminent experts from Academia and Industry.

We hope this lays an excellent platform to share your best Oncology & cancer practice initiative, research project, or provide continuing education as it relates current topics and advances around the industries and field of research. Blood Cancer 2022 provides participants with breakout sessions highlighting clinical projects, education, and research studies. The conference on Oncology & cancer has engaging interactive presentations, and keynote panel discussions with key policymakers and experts in Oncology & cancer

Scientific Sessions/Tracks

Tack 1: Cancer Cell Biology & Genetics

Cancer may be a group of diseases involving abnormal growth of the cells with the potential to invade or unfold to numerous elements of the body. These contrast with benign , that do not spread. Cancer cells are cells that divide unrelentingly, forming solid tumors or flooding the blood with abnormal cells. Cell division may be a traditional method utilized by the body for growth and repair. A parent cell divides to form two daughter cells, and these daughter cells are used to build new tissue or to replace cells that have died because of aging or damage.

Related Societies:

Europe: European Society For Medical Oncology , Rational Therapy for blood Cancer, European Society of Preventive Medicine , Association Vivre sans Thyroid, Dutch Endocrine Society, European Laryngological Society, European Society of Endocrinology, French Endocrine Society, German Society of ORL HNS, German Thyroid Cancer Survivors Association .

Asia Pacific & Middle East: Asian Blood Cancer Society, Asian Health Coalition, Asian Cancer Foundation , Asian Pacific Prostate Society, Asia-Pacific Cancer Society, Asia Pacific Neuro Endocrine Tumor Society, Asian Society of Head & Neck Oncology, Asian and Oceania Thyroid Association, Asia-Pacific Society of Thyroid Surgery, Brazilian Society of Head and Neck Surgery.

America: American Association of Endocrine Surgeons, American Association of Clinical Endocrinologists, American Head and Neck Society, American Thyroid Association, Association of Women Surgeons, Australian and New Zealand Endocrine Surgeons, Australian Society of Otolaryngology Head & Neck Surgery, British Association of Head and Neck Oncology , Canadian Association of Pathologists.

Track2: Various Blood Cancers & their Management

There are mainly three types of blood cancers. Leukemia is one type of cancer it is found in bone marrow and blood. It is affected by the quick production of abnormal white blood cells. These abnormal white blood cells are not able to fight infection and damage the capability of the bone marrow to produce red blood cells and platelets. Lymphoma will be directly attack the immune system, these are called lymphocytes. Lymphoma cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body.

Related Societies:

Track 3: Blood Cancer Diagnosis & Treatment

To confirm the presence of cancer and the severity or the stages of the cancer numerous cancer detection tests are carried out; certain cancer blood tests or alternative laboratory tests, such as an analysis of your urine or a biopsy of a suspicious area, to help guide the diagnosis .

Types of treatments:

Intensive treatment / high-intensity treatment
Chemotherapy
Stem cell transplantation
Radiation therapy
Non-intensive / low-intensity treatment
Low-dose chemotherapy
Curative treatment

Related Societies:

Track 4: Blood oncology and Blood Disorders

Anemia is the most common type of blood disorder. Anemia frequently remains undiagnosed because it is an underlying condition of other health issues, including cancer, cardiovascular disease, diabetes, Hemophilia is a rare, typically inherited blood disorder in which the blood does not properly clot and causes excessive bleeding, which can cause damage to organs, joints, and tissues. The patient may suffer excessive bleeding from the site of an injury or from internal bleeding. Clotting Disorders

Related Societies:

Track 5: Cancer Biomarkers

A cancer biomarker refers to a substance or process that's indicative of the presence of cancer within the body. A biomarker is also a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers are often used for cancer diagnosing, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum.

Breast : ER/PR (estrogen receptor/progesteron receptor), HER-2/neu

Colorectal : EGFR , KRAS, UGT1A1

Gastric : HER-2/neu

GIST : c-KIT

Related Societies:

Track 6: Cancer Clinical Trials

Clinical trials are studies in which people volunteer to take part in tests of latest medication or procedures. Doctors use clinical trials to develop new treatments for serious diseases like cancer.In this section you can learn about clinical trials in general, find tools to help you decide if a clinical trial may be right for you, and search for specific studies you may be eligible to take part in.

Related Societies:

Track 7: Hemato Immunology &Stem Cell Research

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology.

Related Societies:

Track 8: Bone Marrow Transplantation and surgery

Bone Marrow Transplantation: A bone marrow transplant, also known as a haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow stem cells.Bone marrow is a spongy tissue found within the hollow centres of some bones.It contains specialist stem cells, which produce the body's blood cells. A biopsy may be a sample of tissue taken from the body in order to look at it more closely.

Related Societies:

Track 9: Traditional and Alternative Medicine for Blood Cancer

Traditional, complementary and different treatment may also be known as ‘therapy’ or ‘medicine’. These treatments are sometimes called ‘holistic’ because they don’t just look at how the disease affects the body, they aim to treat the whole person – emotionally, mentally and spiritually as well as physically. Also the terms "complementary" and "alternative" are here and there used to allude to non-customary strategies for diagnosing, counteracting, or treating cancer or its symptoms overs the same techniques as complementary medicine and the expression is used when these therapies are used instead of conventional treatments.

Related Societies:

Track 10: Haematological malignancies

Hematologic malignancies are forms of cancer that begins within the cells of blood-forming tissue, like the bone marrow, or in the cells of the immune system.Examples of hematologic cancer are acute and chronic Leukemia, lymphomas, multiple myeloma and myelodysplastic syndromes. This scientific session will focus on all types of common or rare blood cancers such as acute promyelocytic leukemia (APL) and chronic myelomonocytic leukemia hairy cell leukemia (HCL), large granular lymphocytic leukemia (LGL), t-cell acute lymphoblastic leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma, Multiple myeloma, Childhood Leukemia and Myelodysplastic–Myeloproliferative diseases.

Related Societies:

Trcak 11: Drugs for Leukemia, Lymphoma and Myeloma

The information is about a portion of the more current, directed medication medicines for blood tumour that are beginning to be utilized or have been as of late affirmed for use in individuals with Blood Cancer. The list includes generic and brand names. Chemotherapy is the utilization of medicines to crush or control malignancy cells. These medications can be taken by mouth or given in a vein or a muscle. They enter the circulation system and achieve all regions of the body

Leukemia Drugs:

Arranon (Nelarabine)
Asparaginase Erwinia chrysanthemi
Hyper-CVAD

Lymphoma Drugs:

Doxorubicin
Bleomycin
Vinblastine

Myeloma Drugs:

Melphalan
Vincristine (Oncovin)
Cyclophosphamide (Cytoxan)

Related Societies:

Track 12 : Advanced Therapies in Blood Cancer

The most important cancer cure technologies are combined with natural therapies to help patent fight the disease and maintain patent quality of life. Cancer also tested by chemotherapy, radiation therapy, surgery, hormonal therapy, immunotherapy and synthetic lethality. This therapy is depends upon the grade and place of the tumor and also, the stage of the disease, as well as the general state of the patient.

Types of therapies:

Radiofrequency Ablation
Cryosurgical Ablation (CSA)
Cancer Microvascular Intervention (CMI)
NanoKnife Therapy
Photodynamic Therapy
Immunotherapy
Hyperthermia

Related Societies:

Track 13: Cancer Screening & Chemotherapy

Cancer screening aims to find cancer before symptoms appear. This may involve blood tests, urine tests, DNA tests other tests, or medical imaging. Different varieties of cancer screening procedures have completely different risks, butsensible tests share some characteristics. If a test detects cancer, then that test result should conjointly result in choices for treatment.

Related Societies:

Track 14: Neurological Cancers & Brain Tumors

Neuro-oncology is the study of brain and spinal cord neoplasms, many of that are very dangerous and life-threatening astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine brain tumour, and brain stem tumors are among the many examples of these. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma are among the worstA tumor occurs once abnormal cells form inside the brain.

Related Societies:

Track 15: Cancer : Traetment and Therapy

Cancer can be treated by different processes. Many experimental cancer treatments are also under development.Some of the individuals with cancer can have only one treatment.But the majority have a combination of treatments, like surgery with therapy and/or radiotherapy.You also have immunotherapy, targeted therapy, or hormone therapy

Related Societies:

Track 16: Cancer Vaccines

A cancer vaccine is a vaccine, that either treats existing cancer or prevents the development of cancer. Vaccines that treat existing cancer are called therapeutic cancer vaccines.Some/many of the vaccines are "autologous", being ready from samples taken from the patient, and are specific to it patient. Some kinds of cancer, like cervical cancer and some liver cancers, are caused by viruses (oncoviruses). traditional vaccines against those viruses, like HPV immunogen and hepatitis B vaccine, prevent those kinds of cancer.

Related Societies:

Abstract Submission Criteria & Eligibility

PRESENTATION REQUIREMENTS:

Presenting authors are responsible for registration, travel, and hotel costs. Note: Those with accepted abstracts will receive an acceptance mail allowing them to register for the conference.
Abstracts will be compiled and conference books are made available to participants at the conference.
Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

Oral paper presentations will have 30-minute time slots and be clustered by theme into sessions. The keynote session will have for 45-minute time slot, workshop/ special session will have 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute Q&A session.
Graduate & Masters students are eligible to submit their abstracts under poster and e-poster presentation category.
Ph.D. students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and e-poster presentation category.

NOTE: YRF category includes short oral presentation especially for Ph. D. students

Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

Market Analysis

Most cancers are the second leading cause of dying global. It’s crucial to take into account that most cancers aren’t one disease it’s more than 200 most cancers illnesses involved. All distinctive, unique diseases, which require distinctive procedures for treatment. Treatments that paintings for some cancers don’t work for others and every so often those remedies surely prevent operating. Simplest worldwide research will beautify our expertise of cancer and help us find and increase better, extra effective treatments. And best a global search for answers will assist us become familiar with this sickness. . The conference will provide with a tremendous opportunity for the delegates from Universities and Institutes to interact with the sector elegance Scientists and enterprise specialists operating in the discipline of cancer (or) oncology

Blood cancer 2022 may even discover the brand new ideas and ideas on worldwide scale and the subjects most cancers Biology & Genetics, Organ-defined Cancers, Oncology: Sub-Specialities, Radiation Oncology, Surgical Oncology, most cancers & Stem cell therapy, Precision most cancers medicinal drug & Oncology, most cancers Biomarkers, most cancers Epidemiology, cancer Prevention & research, most cancers therapy & remedies, most cancers Pharmacology, cancer Vaccines, most cancers Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & alternative strategies and most cancers, most cancers focus and Survival, most cancers: life-style and vitamins, most cancers: psychological & Social elements

Target market:

Professors, Director’s, studies pupils, commercial specialists, Biomedical and healthcare sectors, Oncologists, Pathologists, Haematologists, Immunologists, medical Researchers, Scientists, enterprise marketers, education Institutes, cancer studies students, most cancers research school, most cancers Researchers, Gynaecologists, Obstetricians, clinical colleges, cancer institutions and Societies, Physicians, Healthcare Scientists and Professors, Breast cancer Surgeons, Pathologists, Radiologists, Nurse Practitioners/Nurses, Chemotherapists, scientific gadgets manufacturing corporations, Pharmaceutical agencies, Diagnostics companies, business marketers, main pharmaceutical leaders, medical doctors, fitness care experts, molecular diagnosticians, clinicians, researchers, Executives/Managers and commercial enterprise Delegates, Universities, Industries, Investigators, post-Doctoral Fellows, studies & Diagnostic Laboratories, clinical Fellows, Biomedical research organizations.

Glance at the market:

The current improvements inside the most cancers treatments & most cancers care are accelerating. A cluster of progressive remedies, frequently blended with other new or current medicines, and regularly associated with biomarkers, are emerging from the research and development pipeline.

Over the last 5 years, 70 new oncology treatments were released and are getting used to deal with over 20 special tumour types.

The global most cancers biomarker marketplace length was worth USD 10.3 billion inside the 12 months 2016 and is estimated to reach a value of USD 33.7 billion by way of 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing consciousness on improvement of focused treatment options is a prime component affirming boom of this market.

Global cancer drugs marketplace accounted for $seventy eight, 238.9 million in 2015. The most cancers drugs marketplace is driven by using the growing occurrence of numerous sorts of most cancers, increasing demand of biological and centered drug treatment plans, non-stop patent expiry of key cancer pills and the growing impact of bio similars. Global Oncology/most cancers drugs marketplace is anticipated to garner $111.9 billion by using 2020, registering a CAGR of seven.1% in the course of the forecast length 2014 to 2020. Recent development in organic therapies has widened the scale of healing goals for remedy of most cancers with the identification of tumour mobile particular genes.

The global most cancers diagnostics market is segmented primarily based on era, application, and region.

This document studies the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to attain $thirteen.1 Billion by way of 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% at some stage in the forecast length.

To Collaborate Scientific Professionals around the World

Conference Date March 22-23, 2022

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Blood Cancer 2020 Conference

Supported By

Journal of Blood & Lymph Journal of Blood Disorders & Transfusion Journal of Hematology & Thromboembolic Diseases

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Conference Series Conferences gaining more Readers and Visitors

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Blood Cancer 2022

About Conference

Scientific Sessions/Tracks

Abstract Submission Criteria & Eligibility

Market Analysis

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By